JANGOBIO, LLC
Cell therapy using mesenchymal stem cells transplanted into testes to repopulate Leydig and Sertoli cells for testosterone production restoration
- Sector
- Biotech
- Headquarters
- FITCHBURG, WI
- Latest Form D
- $2.4M, Jun 2020
- Total capital
- $2.8M
- Federal grants
- $364K
- 1 award · 2016
- Rank in peer group#399 of 502
- Private capital raised
- $2.4M
- 1 Form D · last Jun 2020
- 76 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 3
- 3 pending · first 2022
- Rank in peer group#28 of 502
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$2.4M
- Federal grantHealth and Human S · Phase I · A Novel Biologic for the Treatment of Hypogonadism$364K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
45months
from JANGOBIO, LLC’s first federal award to its first private round.
- First federal award · Sep 2016
- Health and Human S · $364K
- First Form D · Jun 2020
- $2.4M · 1st Form D
- Awards before first raise
- 1 award
An association in public records, not a cause or a prediction.
Standing among 502 peers
Line = medianBiotech · Molecule
- Federal grantsBelow median
- Granted patents#28 · top 6%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Craig S. AtwoodResearcherExecutive Officer, Director, PromoterLinked by 3 patents · $364K in grants as PI
- Richard S. BowenDirectorNamed in SEC Form D filings
- Robert S. CramerDirectorNamed in SEC Form D filings
- Victor S. MohoneyDirectorNamed in SEC Form D filings
- William S. KohlExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 3 granted of 6- GrantedMethods To Differentiate Stem Cells Into Hormone-producing CellsUSPTOUS 12,551,511
- GrantedMethods to Differentiate Stem Cells into Hormone-Producing CellsUSPTOUS 11,439,668
- PendingMethods To Rebalance The Hypothalamic-pituitary-gonadal AxisUSPTOApplication 17677202
Show all 6 patent records
- Methods To Differentiate Stem Cells Into Hormone-producing CellsFeb 17, 2026 · US 12,551,511Granted
- Methods to Differentiate Stem Cells into Hormone-Producing CellsSep 13, 2022 · US 11,439,668Granted
- Methods To Rebalance The Hypothalamic-pituitary-gonadal AxisAug 4, 2022 · Application 17677202Pending
- Methods To Rebalance The Hypothalamic-pituitary-gonadal AxisFeb 22, 2022 · US 11,253,549Granted
- Methods Of Generating Hormone-producing Organoids And Reversing HypogonadismApplication PCTUS2023063320Pending
- Methods To Differentiate Stem Cells Into Hormone-producing CellsApplication PCTUS2019026305Pending
Related companies, and why
- MindImmune Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Phenovista Biosciences LLCSimilar federal contract value in Biotech · null in contracts
- ELEGEN CORP.Similar federal contract value in Biotech · null in contracts
- GEMNEO BIOSCIENCE, INC.Similar federal contract value in Biotech · null in contracts
- TriAltus Bioscience, LLCSimilar federal contract value in Biotech · null in contracts
- PDX PHARMACEUTICALS, INC.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .